引用本文:孙景宏,隋长百.颅内血肿微创清除术治疗丘脑出血的效果观察[J].中国临床新医学,2016,9(6):510-512.
【打印本页】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 1564次   下载 1061 本文二维码信息
码上扫一扫!
分享到: 微信 更多
颅内血肿微创清除术治疗丘脑出血的效果观察
孙景宏,隋长百
265701 山东,烟台市北海医院神经内科
摘要:
[摘要] 目的 探讨颅内血肿微创清除术治疗丘脑出血的疗效。方法 选取2010-06~2013-06该院住院治疗的丘脑出血患者47例,分为治疗组24例和对照组23例。治疗组给予颅内血肿微创清除术及内科保守治疗,对照组仅给予内科保守治疗。所有患者于术前及术后第1、3、5、10、30天依据美国国立卫生研究所脑卒中评分(NIHSS)测定神经功能缺损评分。结果 治疗组疗效优良率为75.0%,存活率为75.0%,明显高于对照组的43.48%和47.82%(P<0.01)。治疗组病死率为25.0%,明显低于对照组的43.83%(P<0.01)。结论 颅内血肿微创清除术治疗10~20 ml的丘脑出血疗效优良率及存活率明显优于保守治疗。
关键词:  颅内血肿微创清除术  丘脑出血  存活率  病死率
DOI:10.3969/j.issn.1674-3806.2016.06.14
分类号:R 651
基金项目:
The efficacy of minimally invasive removal of intracranial hematoma in treatment of thalamic hemorrhage
SUN Jing-hong, SUI Chang-bai
Department of Neurology, Beihai Hospital of Yantai City, Shandong 265701, China
Abstract:
[Abstract] Objective To investigate the effect of minimally invasive removal of intracranial hematoma in the treatment of thalamic hemorrhage.Methods Forty-seven patients with thalamic hemorrhage during hospitalization in our hospital from June 2010 to June 2013 were divided into the treatment group(n=24) and the control group(n=23). The treatment group was treated with minimally invasive removal of intracranial hematoma and the conservative treatment. The control group was only treated with the conservative treatment. All patients were scored according to NIHSS, 1, 3, 5, 10, and 30 days after the operation.Results The effective rate was 75% in the treatment group and 43.48% in the control group(P<0.01). The survival rate was 75% in the treatment gronp, and 47.82% in the control group(P<0.01). The mortality rate of the treatment group(25.00%) was significantly lower than that of the control group(43.83%)(P<0.01).Conclusion Minimally invasive removal of intracranial hematoma is better than the conservation treatment in the treatment of 10 to 20 ml of thalamic hemorrhage.
Key words:  Minimally invasive removal of intracranial hematoma  Thalamic hemorrhage  Survival rate  Mortality rate